Is it time to reconcile HDL with cardiovascular diseases and beyond? An update on a paradigm shift
- Resource Type
- Authors
- Cécile Ingueneau; Laurent O. Martinez; Annelise Genoux
- Source
- Current Opinion in Lipidology
Current Opinion in Lipidology, Lippincott, Williams & Wilkins, 2020, 31 (5), pp.302-304. ⟨10.1097/MOL.0000000000000705⟩
Current Opinion in Lipidology, 2020, 31 (5), pp.302-304. ⟨10.1097/MOL.0000000000000705⟩
- Subject
- Endocrinology, Diabetes and Metabolism
[SDV]Life Sciences [q-bio]
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Risk Factors
Genetics
Medicine
Humans
Molecular Biology
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Cognitive science
0303 health sciences
Nutrition and Dietetics
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
business.industry
Cholesterol, HDL
Cell Biology
[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
[SDV] Life Sciences [q-bio]
Cardiovascular Diseases
Paradigm shift
Cardiology and Cardiovascular Medicine
business
Biomarkers
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
- Language
- English
- ISSN
- 0957-9672
International audience; No abstract available